Flemington, N.J., May 19, 2016 – ACT Oncology announced today it has been awarded the Philadelphia Alliance for Capital and Technologies (PACT) 2016 Enterprise Award for Emerging Healthcare companies. The Enterprise Awards, held annually, are the region’s most prestigious business honors for innovative life sciences and technology companies, leaders, and entrepreneurs.

(more…)

Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor

Los Angeles, May 17, 2016 — Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.

(more…)

Establishes Bay Area Immune-Response Laboratory Capability

Bethesda, Md. and Redwood City, Calif., May 3, 2016 – Precision for Medicine, part of the Precision Medicine Group, announced today that it has acquired Applied Immunology, an established expert in the creation and delivery of custom cell-based and immunoassay solutions. Applied Immunology supports innovative and targeted therapeutics developers across all areas, ranging from immuno-oncology to rare diseases to biosimilars from research to post-approval. Applied Immunology’s client base includes some of the most pioneering new venture-backed startups, along with many major global pharmaceutical firms.

(more…)

37-Year-Young Advertising Agency Gets a New Name, New Locations and
Expanded Service Offering

Boston, March 29, 2016 – LehmanMillet, the only healthcare communications agency dedicated to working with companies seeking to change the standard of care, has changed its name to precisioneffect (www.precisioneffect.com). The impetus for the name change was the firm’s acquisition by Precision Medicine Group (PMG) in May of 2015. PMG is a specialized services company supporting next-generation approaches to drug development and commercialization.

(more…)